News
- Author:
- Jim Kling
Publish date: May 26, 2023
A new review highlights three mechanical circulatory support options in high-risk patients, but teamwork is key.
News
- Author:
- Jim Kling
Publish date: May 11, 2023
A mouse study suggests an effect on inflammation by boosting bile acid metabolism.
News
- Author:
- Jim Kling
Publish date: May 11, 2023
A propensity-matched analysis found a benefit even after considering lead-time bias, suggesting a real benefit.
News
- Author:
- Jim Kling
Publish date: May 11, 2023
Extraesophageal reflux symptoms are a subset of gastroesophageal reflux disease that can be difficult to diagnose.
News
- Author:
- Jim Kling
Publish date: April 25, 2023
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
News
- Author:
- Jim Kling
Publish date: April 20, 2023
Model uses only digitized histopathology slides, but more validation in other populations is needed.
News
- Author:
- Jim Kling
Publish date: April 20, 2023
A phase 1 clinical trial could provide biomarker clues to help guide future studies.
News
- Author:
- Jim Kling
Publish date: April 20, 2023
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
News
- Author:
- Jim Kling
Publish date: April 17, 2023
Patients with unresectable desmoplastic melanoma experienced a response rate that was nearly double other melanomas.
News
- Author:
- Jim Kling
Publish date: April 7, 2023
Having public or a combination of public and private insurance was associated with worse 10-year overall survival.
News
- Author:
- Jim Kling
Publish date: April 7, 2023
The EMA had fewer approvals and took longer to make decisions.
News
- Author:
- Jim Kling
Publish date: April 7, 2023
But the authors of new research also found potential evidence that industry sponsorship may lead to a spin on QoL outcomes.
News
- Author:
- Jim Kling
Publish date: April 6, 2023
AGA launches My IBD Life campaign to support patients with IBD and encourage providers to play a role.
News
- Author:
- Jim Kling
Publish date: March 13, 2023
A method using gene editing at the two-cell stage recreated in mice the phenotype of a patient with two separate mutations.
News
- Author:
- Jim Kling
Publish date: March 10, 2023
An Irish study pinpoints excuses for putting off screening and discounting one’s risk of colorectal cancer.
